Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Background and AimsThe BALAD score is developed to provide an objective determination of prognosis for hepatocellular carcinoma (HCC) by incorporating five serum markers, namely albumin, bilirubin, alpha-fetoprotein (AFP), agglutinin-reactive alpha-fetoprotein (AFP-L3), and des--carboxy prothrombin. We aim to study the applicability of BALAD score and prognostication of the three tumor markers in hepatitis B virus-related HCC.
著者Chan SL, Mo F, Johnson P, Li L, Tang N, Loong H, Chan AWH, Koh J, Chan ATC, Yeo W
期刊名稱Journal of Gastroenterology and Hepatology
出版年份2015
月份10
日期1
卷號30
期次10
出版社WILEY-BLACKWELL
頁次1529 - 1535
國際標準期刊號0815-9319
電子國際標準期刊號1440-1746
語言英式英語
關鍵詞infection; liver neoplasm; staging
Web of Science 學科類別Gastroenterology & Hepatology

上次更新時間 2020-08-08 於 02:40